Engineering the future of 3D pathology

Author:

Liu Jonathan TC123ORCID,Chow Sarah SL1ORCID,Colling Richard4,Downes Michelle R5,Farré Xavier6ORCID,Humphrey Peter7,Janowczyk Andrew89,Mirtti Tuomas1011,Verrill Clare412ORCID,Zlobec Inti13,True Lawrence D2

Affiliation:

1. Department of Mechanical Engineering University of Washington Seattle WA USA

2. Department of Laboratory Medicine & Pathology University of Washington School of Medicine Seattle USA

3. Department of Bioengineering University of Washington Seattle USA

4. John Radcliffe Hospital University of Oxford Oxford UK

5. Sunnybrook Health Sciences Centre University of Toronto Toronto Canada

6. Public Health Agency of Catalonia Lleida Spain

7. Department of Urology Yale School of Medicine New Haven CT USA

8. Wallace H Coulter Department of Biomedical Engineering Emory University and Georgia Institute of Technology Atlanta GA USA

9. Geneva University Hospitals Geneva Switzerland

10. Helsinki University Hospital and University of Helsinki Helsinki Finland

11. Emory University School of Medicine Atlanta GA USA

12. NIHR Oxford Biomedical Research Centre Oxford University Hospitals NHS Foundation Trust Oxford UK

13. Institute for Tissue Medicine and Pathology University of Bern Bern Switzerland

Abstract

AbstractIn recent years, technological advances in tissue preparation, high‐throughput volumetric microscopy, and computational infrastructure have enabled rapid developments in nondestructive 3D pathology, in which high‐resolution histologic datasets are obtained from thick tissue specimens, such as whole biopsies, without the need for physical sectioning onto glass slides. While 3D pathology generates massive datasets that are attractive for automated computational analysis, there is also a desire to use 3D pathology to improve the visual assessment of tissue histology. In this perspective, we discuss and provide examples of potential advantages of 3D pathology for the visual assessment of clinical specimens and the challenges of dealing with large 3D datasets (of individual or multiple specimens) that pathologists have not been trained to interpret. We discuss the need for artificial intelligence triaging algorithms and explainable analysis methods to assist pathologists or other domain experts in the interpretation of these novel, often complex, large datasets.

Funder

Canary Foundation

Division of Cancer Prevention, National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

National Institute of Diabetes and Digestive and Kidney Diseases

NIHR Oxford Biomedical Research Centre

National Science Foundation

Prostate Cancer UK

U.S. Department of Defense

U.S. National Library of Medicine

UK Research and Innovation

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3